Sarcoma Immunotherapy: Past Approaches and Future Directions

Sarcomas are heterogeneous malignant tumors of mesenchymal origin characterized by more than 100 distinct subtypes. Unfortunately, 25–50% of patients treated with initial curative intent will develop metastatic disease. In the metastatic setting, chemotherapy rarely leads to complete and durable res...

Descripción completa

Detalles Bibliográficos
Autores principales: D'Angelo, S. P., Tap, W. D., Schwartz, G. K., Carvajal, R. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981453/
https://www.ncbi.nlm.nih.gov/pubmed/24778572
http://dx.doi.org/10.1155/2014/391967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981453/
https://www.ncbi.nlm.nih.gov/pubmed/24778572
http://dx.doi.org/10.1155/2014/391967

Ejemplares similares